Features - Brilinta

Filter

Current filters:

Brilinta

Popular Filters

10 to 34 of 66 results

Pharma Summit: Rethinking the future – new business models for pharma

Pharma Summit: Rethinking the future – new business models for pharma

14-03-2014

The way pharma works needs to change with an increasing focus on collaborations, sharing data and access…

HealthcareInterviewsLundbeckPfizerPharmaceuticalPricingUK

Exclusive: Changing pharma marketplace means new dynamics to deal with, says Mundipharma executive

11-02-2014

The pharmaceutical market is changing, says Georg Toufar, chief marketing officer of Mundipharma International,…

InterviewsManagementMarkets & MarketingMundipharmaPharmaceutical

Faster, better, safer: How clinical trials can be transformed by Equivital wearable technology

Faster, better, safer: How clinical trials can be transformed by Equivital wearable technology

04-02-2014

A UK-based mobile human monitoring company is making waves in health care as it aims to revolutionize…

BiotechnologyInterviewsPharmaceuticalResearchUK

EXPERT VIEW: Pharmaceutical firms “can’t keep ignoring information risk”

28-01-2014

Knowledge is the lifeblood of the pharmaceutical sector. From raw experimental data to complex chemical…

EuropeInterviewsManagementPharmaceutical

Atherothrombotic diseases market to grow to $47 billion in 2022

Atherothrombotic diseases market to grow to $47 billion in 2022

23-12-2013

The launch of numerous add-on therapies in the atherothrombotic diseases market (incorporating pharmacotherapies…

AstraZenecaBayerBrilintaCardio-vascularEli LillyevacetrapibGlobalMarkets & MarketingPharmaceuticalXarelto

Genesis 2013: Secrets of B-MS and AstraZeneca Amylin deal revealed

Genesis 2013: Secrets of B-MS and AstraZeneca Amylin deal revealed

16-12-2013

Secrets of how Bristol-Myers Squibb and AstraZeneca arranged a behind-the-scenes deal to buy Amylin were…

AmylinAstraZenecaBristol-Myers SquibbDiabetesInterviewsLegalMergers & AcquisitionsPharmaceuticalUKUSA

Genesis 2013: Biotech urged to consider NHS partnering and venture capital

Genesis 2013: Biotech urged to consider NHS partnering and venture capital

16-12-2013

The UK’s brightest bioscience companies met in London for the One Nucleus Genesis 2013 conference on…

BiotechnologyFinancialInterviewsMerck SeronoResearchUK

FT Pharma 2013: Panel discusses diversity needed in high-level positions

FT Pharma 2013: Panel discusses diversity needed in high-level positions

04-12-2013

A Twitter debate was sparked yesterday after the Financial Times Global Pharmaceutical & Biotechnology…

GlobalHealthcareInterviewsPharmaceuticalPolitics

FT Pharma 2013: NICE chair David Haslam says “I want as many yeses as possible”

FT Pharma 2013: NICE chair David Haslam says “I want as many yeses as possible”

04-12-2013

The chair of the UK’s regulatory body the National Institute for Health and Care Excellence shared…

InterviewsPharmaceuticalRegulationUK

FT Pharma 2013: Bayer chairman Marijn Dekkers says “patients don’t appreciate us”

FT Pharma 2013: Bayer chairman Marijn Dekkers says “patients don’t appreciate us”

03-12-2013

Most patients don’t appreciate the pharma companies that save their lives, Bayer chairman Marijn Dekkers…

BayerHealthcareInterviewsPharmaceuticalPoliticsUSA

FT Pharma 2013: AstraZeneca CEO Pascal Soriot on Brilinta, MedImmune and the UK’s ‘Golden Triangle’

FT Pharma 2013: AstraZeneca CEO Pascal Soriot on Brilinta, MedImmune and the UK’s ‘Golden Triangle’

03-12-2013

The UK’s ‘Golden Triangle’ of biotech innovation can compete on the world stage, AstraZeneca (LSE:…

AstraZenecaBoardroomBrilintaInterviewsPharmaceuticalUK

Interview: Clinigen’s CEO Peter George on the company’s record growth

Interview: Clinigen’s CEO Peter George on the company’s record growth

15-11-2013

If there is one pharma company bucking the trend of shaky financial results it is the Clinigen Group.

BoardroomClinigen GroupFoscavirInterviewsOncologyPharmaceuticalRare diseasesUK

AstraZeneca initiates two additional global studies with Brilinta

AstraZeneca initiates two additional global studies with Brilinta

14-11-2013

Anglo-Swedish drug major AstraZeneca plans to conduct two new clinical studies as part of PARTHENON,…

AstraZenecaBrilintaCardio-vascularPharmaceuticalResearch

AstraZeneca “cooperating” with US DoJ inquiry into Brilinta trial

AstraZeneca “cooperating” with US DoJ inquiry into Brilinta trial

01-11-2013

AstraZeneca said it is cooperating with the US Department of Justice after an investigation has been…

AstraZenecaBrilintaCardio-vascularEuropeLegalPharmaceutical

EXPERT VIEW: Talent acquisition at the heart of M&A

EXPERT VIEW: Talent acquisition at the heart of M&A

22-10-2013

Mergers and acquisitions are common – 111 M&As took place in the UK in the second quarter of 2013 alone…

BoardroomInterviewsMergers & AcquisitionsPharmaceutical

BIA UK BioScience Forum: Accelerating vaccine development

BIA UK BioScience Forum: Accelerating vaccine development

15-10-2013

Recent advances in vaccine development in the UK were heard by interested delegates at the UK BioScience…

BiotechnologyEuropeInterviewsResearchVaccines

BIA UK BioScience Forum: The benefits of the European Unitary Patent

BIA UK BioScience Forum: The benefits of the European Unitary Patent

14-10-2013

Updates on Intellectual Property developments in Europe were heard by delegates at the BIA UK BioScience…

EuropeInterviewsPatentsPharmaceutical

IN FOCUS: Using the body’s own defenses against cancer - Scancell reveals its immunotherapy products

IN FOCUS: Using the body’s own defenses against cancer - Scancell reveals its immunotherapy products

07-10-2013

UK-based cancer therapeutics firm Scancell, developer of novel immunotherapies, gathered its investors…

BiotechnologyEuropeFinancialInterviewsOncologyScancell

IN FOCUS: A post-ERS look at Verona Pharma’s respiratory pipeline

IN FOCUS: A post-ERS look at Verona Pharma’s respiratory pipeline

20-09-2013

Fresh from their trip to the European Respiratory Society annual congress in Barcelona, Verona Pharma’s…

EuropeInterviewsPharmaceuticalResearchRespiratory and Pulmonary

10 to 34 of 66 results

Back to top